{\rtf1\deflang1033\deflangfe1033\margl720\margr720\margt360\margb360{\stylesheet{\fs20\lang1033\snext0 Normal;} {\s1\sb240\keepn{\*\pn \pnlvl1\pndec\pnprev1\pnstart1\pnsp144}\b\f0\fs30\lang1033 \sbasedon0\snext0 heading 1;} {\s2\sb200\keepn{\*\pn \pnlvl2\pndec\pnprev1\pnstart1\pnsp144{\pntxtb.}}\b\f0\fs26\lang1033 \sbasedon0\snext0 heading 2;} {\s3\sb180\keepn{\*\pn \pnlvl3\pndec\pnprev1\pnstart1\pnsp144{\pntxtb.}}\b\f0\fs22\lang1033 \sbasedon0\snext0 heading 3;} {\s4\sb160\keepn{\*\pn \pnlvl4\pnucltr\pnprev1\pnstart1\pnsp144{\pntxtb.}}\b\f0\fs22\lang1033 \sbasedon0\snext0 heading 4;} {\s5\sb140\keepn{\*\pn \pnlvl5\pncltr\pnprev1\pnstart1\pnsp144}\b\f0\fs20\lang1033 \sbasedon0\snext0 heading 5;} {\s6\tqc\lang1033\sbasedon0\snext6 footer;} {\*\cs16 \additive\super\sbasedon10 footnote reference;} {\*\cs18 \additive\sbasedon10 page number;}} {\fonttbl{\f0\fnil Times New Roman;}{\f1\fnil Courier New}{\f2005\fnil Courier New;}{\f2010\fnil Wingdings;}{\f2020\fnil Webdings;}{\f2\fnil Arial;}{\f3\fnil Arial;}{\f4\fnil LucidaHandwriting;}{\f5\fnil Symbol;}{\f6\fnil Symbol;}{\f7\fnil Ferdsch;}{\f30\fnil Myriad Cn Semibold;}{\f31\fnil Myriad Roman;}{\f50\fnil Courier New;}{\f51\fnil Times New Roman;}{\f52\fnil Arial;}{\f53\fnil Symbol;}{\f54\fnil Wingdings;}{\f55\fnil Wingdings 2;}{\f56\fnil Wingdings 3;}{\f57\fnil Webdings;}{\f58\fnil Arial Narrow;}{\f59\fnil Arial Unicode MS;}{\f60\fnil Cyberbit;}{\f61\fnil Morningstar 1U Light;}{\f62\fnil Calibri;}} {\colortbl;\red0\green0\blue0;\red127\green0\blue0;\red0\green0\blue255;\red127\green127\blue127;\red0\green51\blue153;\red255\green204\blue0;\red255\green255\blue255;\red246\green244\blue236;\red0\green0\blue0;} {\*\bkmkstart filing_1}{\*\bkmkend filing_1}{\*\bkmkstart doc_1_1}{\*\bkmkend doc_1_1} \par\pard\plain\fs16 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql SECURITIES AND EXCHANGE COMMISSION \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Washington, D.C. 20549 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql ________________________ \par\pard\plain\fs16 \par\pard\plain\fs16 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql FORM 8-K \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql CURRENT REPORT \par\pard\plain\fs16 \par\pard\plain\fs16 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Pursuant to Section 13 or 15 (d) of the \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Securities Exchange Act of 1934 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Date of Report (Date of earliest event reported) \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql June 14, 2001 \par\pard\plain\fs16 \par\pard\plain\fs16 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql FMC CORPORATION \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql -------------------------------------------------------------------------- \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql (Exact name of registrant as specified in its charter) \par\pard\plain\fs16 \par\pard\plain\fs16 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Delaware 1-2376 94-4079804 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql ---------------------------- ------------ ------------------- \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql (State or other jurisdiction (Commission (I.R.S. Employer \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql of incorporation) File Number) Identification No.) \par\pard\plain\fs16 \par\pard\plain\fs16 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql 200 East Randolph Drive, Chicago, Illinois 60601 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql -------------------------------------------------------------------------- \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql (Address of principal executive offices) (Zip Code) \par\pard\plain\fs16 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql (312) 861-6000 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql ------------------------------ \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Registrant's telephone number, \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql including area code \par\pard\plain\fs16 \page \par\pard\plain\fs16{\*\bkmkstart part_1_2_1}{\*\bkmkend part_1_2_1}{\*\bkmkstart item_1_47_1}{\*\bkmkend item_1_47_1}\pard\plain\cf1\f50\fs16\ql Item 7. Financial Statements and Exhibits. \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql (c) Exhibits. The following exhibit is furnished as part of this report to \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql the extent described in Item 9. \par\pard\plain\fs16 \par\pard\plain\fs16 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql -------------------------------------------------------------------------------- \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Exhibit Number Topic Presenter \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql -------------------------------------------------------------------------------- \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Exhibit 99a FMC Corporation--Increasing William G. Walter \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Shareholder Value \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql -------------------------------------------------------------------------------- \par\pard\plain\fs16 \par\pard\plain\fs16{\*\bkmkstart part_1_2_2}{\*\bkmkend part_1_2_2}{\*\bkmkstart item_1_45_1}{\*\bkmkend item_1_45_1}\pard\plain\cf1\f50\fs16\ql Item 9. Regulation FD Disclosure. The Merrill Lynch Chemical Conference was \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql held on June 14, 2001 in Chicago, IL. A slide presentation made at the meeting \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql by William G. Walter, Executive Vice President, FMC Corporation, is attached \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql hereto as an exhibit to this report. These slides may also be accessed at the \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql company's website (www.fmc.com). The posting and furnishing of this information \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql is not intended to, and does not, constitute a determination by FMC Corporation \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql that the information is material or that investors should consider this \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql information before deciding to buy or sell FMC securities. \par\pard\plain\fs16 \page \par\pard\plain\fs16{\*\bkmkstart part_1_2_3}{\*\bkmkend part_1_2_3}\pard\plain\cf1\f50\fs16\ql SIGNATURE \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Pursuant to the requirements of the Securities Exchange Act of 1934, the \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Registrant has duly caused this report to be signed on its behalf by the \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql undersigned thereunto duly authorized. \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql FMC CORPORATION \par\pard\plain\fs16 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql By /s/ Stephen F. Gates \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql --------------------- \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Stephen F. Gates \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Senior Vice President, General \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Counsel and Secretary \par\pard\plain\fs16 \par\pard\plain\fs16 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Date: June 15, 2001 \par\pard\plain\fs16 \par\pard\plain\fs16 \page{\*\bkmkstart doc_1_2}{\*\bkmkend doc_1_2} \par\pard\plain\fs16 \page \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql EXHIBIT 99(a) \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql FMC Presentation at Merrill Lynch Chicago Chemical Conference, June 14, 2001 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql "Increasing Shareholder Value" \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Slide 1 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql FMC \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Increasing Shareholder Value \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql -------------------------------------------------------------------------------- \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Slide 2 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Disclaimer \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Statement under the Safe Harbor Provisions of the Private Securities Litigation \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Reform Act of 1995: These slides and the accompanying presentations contain \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql "forward-looking statements," which represent management's best judgment as of \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql the date hereof based on information currently available. Actual results of the \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Company may differ materially from those contained in the forward-looking \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql statements. Additional information concerning factors that may cause results to \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql materially differ from those in the forward-looking statements is contained in \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql the Company's periodic reports filed under the Securities Exchange Act of 1934, \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql as amended. The Company undertakes no obligation to update or revise these \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql forward-looking statements to reflect new events or uncertainties. \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql -------------------------------------------------------------------------------- \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Slide 3 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Presentation Contents \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Spin-off of FMC Technologies \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .FMC Corporation \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql -Agricultural Products \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql -Specialty Chemicals \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql -Industrial Chemicals \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql -------------------------------------------------------------------------------- \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Slide 4 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Spin-off of FMC Technologies \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql [Organization Chart] \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql FMC \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql FMC FMC Technologies \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Industrial Specialty Agricultural Energy Food & \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Chemicals Chemicals Products System Transportation \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Systems \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql ================================================================================ \par\pard\plain\fs16 \par\pard\plain\fs16 \page \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Slide 5 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Spin-off of FMC Technologies \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql $3.9B Sales [Pie Chart] $436M Operating Profit [Pie Chart] \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Industrial Chem. $906M Industrial Chem. $115M \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Ag Products $665M Ag. Products $ 88M \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Specialty Chem. $489M Specialty Chem. $ 92M \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Food & Trans. Systems $839M Food & Trans. Systems $ 69M \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Energy Systems $1,037M Energy Systems $ 72M \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql FMC Technologies FMC Technologies \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql -------------------------------------------------------------------------------- \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Slide 6 \par\pard\plain\fs16 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Spin-off of FMC Technologies \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql The spin-off will provide both companies with: \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Increased management focus \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Increased customer and market focus \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Ability to adopt capital structures aligned with industry peers of each \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql business \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Ability to reward employees with equity compensation tied to businesses \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql -------------------------------------------------------------------------------- \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Slide 7 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Spin-off of FMC Technologies \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .IPO of approximately 17% of FMC Technologies completed June 14th \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Distribution of remaining shares of FMC Technologies to FMC shareholders by \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql year end \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Shareholders will receive or retain: \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql -If distribution by dividend: \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Retain 1 share FMC Corporation (chemicals) \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Receive ~1.7 shares of FTI per share of FMC \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql -Or if distribution by exchange: \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Receive option to exchange FMC Corporation stock for FMC Technologies \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql stock \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql -------------------------------------------------------------------------------- \par\pard\plain\fs16 \par\pard\plain\fs16 \page \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Slide 8 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql FMC (Chemicals) \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql --------------- \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql [Pie Chart] \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Industrial Chemicals $1,106 M \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Specialty Chemicals $489 M \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Ag Products $665 M \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Sales $2,260 M \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Industrial chemicals sales includes FMC's half of Astaris sales. \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql -------------------------------------------------------------------------------- \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Slide 9 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql FMC (Chemicals) History \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql ----------------------- \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql [Summation Bar Graph] \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql EBIT ($M) \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql 1997 1998 1999 2000 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql ---- ---- ---- ---- \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Agricultural 35 76 64 88 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Industrial 77 78 73 92 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Specialty 136 117 145 115 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Corporate & \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Other (44) (42) (32) (27) \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Total 204 230 250 268 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql 9.5% CAGR (1997-2000) \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql -------------------------------------------------------------------------------- \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Slide 10 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql FMC (Chemicals) Debt Post-IPO \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql ----------------------------- \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql 12/31/00 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql -------- \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql FMC Corporation total debt 1,049 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Less: debt transferred to FMC Technologies 315 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Less: estimated net IPO proceeds 205 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql -------- \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql =Proforma FMC (Chemicals) debt post-IPO 529 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql -------- \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Anticipated average debt to be $750M for 2001. \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql -------------------------------------------------------------------------------- \par\pard\plain\fs16 \par\pard\plain\fs16 \page \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Slide 11 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql FMC (Chemicals) Earnings Perspective \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql ------------------------------------ \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql 1997 1998 1999 2000 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql ------ ------ ------ ------ \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Revenue $2,414 $2,384 $2,338 $2,260 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql EBIT ex-spec. ch. 204 230 250 268 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql EBIT / Revenue 8.5% 9.7% 10.7% 11.9% \par\pard\plain\fs16 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Interest expense 55 55 55 55 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Tax (23.5% est. avg. rate) 35 41 46 50 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Net Income 114 134 149 163 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Net Income per share $ 3.54 $ 4.16 $ 4.63 $ 5.06 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Pro forma Notes: \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql ---------------- \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Sales include 1/2 Astaris sales and required restatement of shipping costs. \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Estimated proforma interest expense based on estimated $750M average debt level \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql and FMC's 2000 average interest rate. \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Using 1Q 2001's average shares outstanding (32.2M) for each proforma period. \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql ________________________________________________________________________ \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Slide 12 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql FMC (Chemicals) Overview of Segments \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql ------------------------------------ \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Number 1 or 2 market position in most product lines \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Focus on low cost production in Industrial Chemicals \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Focus on R&D / innovation in Agricultural Chemicals \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Development of high growth, high return Specialty Chemical applications \par\pard\plain\fs16 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql ________________________________________________________________________ \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Slide 13 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Agricultural Products Group \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql --------------------------- \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Sales $665M \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Sales by Product Sales by Region \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql [Pie Chart] [Pie Chart] \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Insecticides $489M Asia $128M \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Herbicides $176M Mexico/Latin America $173M \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql North America $201M \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Europe, Middle East, Africa $83M \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Specialty $80M \par\pard\plain\fs16 \page \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql ________________________________________________________________________ \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Slide 14 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Agricultural Products Group \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql --------------------------- \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql APG strengths \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Strong insecticide position \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Growing herbicide position \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Growing specialty non-crop \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .R&D Focus \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql ________________________________________________________________________ \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Slide 15 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Agricultural Products Group \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql --------------------------- \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql New Herbicide \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql . Carfentrazone - new herbicide with annual sales potential of $125M - \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql $150M in next few years \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql R&D \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Finding new molecular target sites sensitive to chemicals can provide a \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql rapid and cost-effective means of uncovering new classes of insecticides \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .FMC partnership with Devgen provides key technologies \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .The first target site generated by this partnership is entering high \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql throughput screening \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql ________________________________________________________________________ \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Slide 16 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Agricultural Products Group \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql --------------------------- \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql **2000 Results: Strong earnings improvement from 1999 as pest pressures returned \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql ------------- \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql to more normal levels \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql **2001 Forecast: Expect profits up over 2000 from label expansions on \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql -------------- \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql insecticides and herbicides, continued cost reductions. Issues surrounding \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql genetically modified crops should benefit FMC \par\pard\plain\fs16 \par\pard\plain\fs16 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql [Bar Graph] 1994 1995 1996 1997 1998 1999 2000 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql ----- ----- ----- ----- ----- ----- ----- \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Sales ($ Millions) $ 517 $ 590 $ 650 $ 638 $ 648 $ 632 $ 665 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql [Overlapping Line Graph] \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql % EBITDA Margin 19.0% 19.8% 17.8% 10.0% 16.3% 13.8% 17.1% \par\pard\plain\fs16 \page \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql [photo of agricultural products] \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql ________________________________________________________________________ \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Slide 17 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Specialty Chemicals Group \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql ------------------------- \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Sales $489M \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql [Pie Chart] \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql BioPolymer $351M \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Lithium $138M \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql ________________________________________________________________________ \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Slide 18 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Specialty Chemicals Group \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql ------------------------- \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql BioPolymer: Growing Global Businesses \par\pard\plain\fs16 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Total Growth \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Business Sales Prospects \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Pharmaceuticals 37% 4-5% \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Food Ingredients 42% 4-5% \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Specialty 21% 6-7% \par\pard\plain\fs16\par\pard\plain\cf1\f50\fs16\ql ________________________________________________________________________ \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Slide 19 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Specialty Chemicals Group \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql ------------------------- \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql BioPolymer: Sales by product and function \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Sales by product Sales by function \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql [Pie Chart] [Pie Chart] \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Algin 19% Specialty 21% \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql MCC 36% Food Ingredients 42% \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql CGN 37% Pharmaceutical 37% \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Other 8% \par\pard\plain\fs16\par\pard\plain\cf1\f50\fs16\ql ________________________________________________________________________ \par\pard\plain\fs16 \page \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Slide 20 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Specialty Chemicals Group \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql ------------------------- \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql FMC Lithium Strategy \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Unique chemical properties of lithium \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Focused resources on downstream specialty opportunities \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Profitability hurt by commodity competition \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Maintained manufacturing cost position of high-value lithium \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Growth opportunities: \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql -Lifetime/(R)/ and Renew/(R)/ ASR concrete technologies \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql -Electric and hybrid electric vehicles \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql [Two photos of vehicles] \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql ________________________________________________________________________ \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Slide 21 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Specialty Chemicals Group \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql ------------------------- \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql **2000 Results: Sales lower from PAD divestiture, but profits up from successful \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql ------------- \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Pronova integration. Lithium sales & profits up, but market remained difficult \par\pard\plain\fs16 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql **2001 Forecast: Both businesses' profits approximately flat with strong 2000. \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql -------------- \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Continuing Pronova synergies in BioPolymer. \par\pard\plain\fs16 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql [Bar Graph] 1994 1995 1996 1997 1998 1999 2000 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql ---- ---- ---- ---- ---- ---- ---- \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Sales ($ Millions) $544 $588 $602 $605 $598 $565 $489 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql [Overlapping Line Graph] \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql % EBITDA Margin 20.5% 18.1% 17.1% 19.3% 19.2% 19.5% 26.0% \par\pard\plain\fs16\par\pard\plain\cf1\f50\fs16\ql [customer logos: Lilly, Merck, Novartis, Pfizer, Johnson & Johnson] \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql ________________________________________________________________________ \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Slide 22 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Industrial Chemicals Group \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql -------------------------- \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Sales $1.106B \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql [Pie Chart] \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Peroxygens $189M \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Foret SA $233M \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Phosphorus $278M \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Alkali $406M \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Includes FMC's portion of Astaris' sales \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql ________________________________________________________________________ \par\pard\plain\fs16 \page \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Slide 23 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Industrial Chemicals Group \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql -------------------------- \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql ICG Overview \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Strong market positions \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Low cost positions \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Phosphorus / Astaris \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql ________________________________________________________________________ \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Slide 24 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Industrial Chemicals Group \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql -------------------------------- \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Strong Market Positions: \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Market Share \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql ------------ \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql N. America Europe \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Hydrogen Peroxide 26% 10% \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Soda Ash 34% - \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Phosphates 55% 15% \par\pard\plain\fs16\par\pard\plain\cf1\f50\fs16\ql ________________________________________________________________________ \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Slide 25 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Industrial Chemicals Group \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql -------------------------- \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Continued focus on cost reductions \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Soda ash capacity rationalization \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .New purified phosphoric acid plant \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Hydrogen peroxide cost reductions \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql ________________________________________________________________________ \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Slide 26 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Industrial Chemicals Group \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql -------------------------- \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Phosphorus / Astaris \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Astaris JV (combination of FMC and Solutia phosphorus businesses) \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql -Strong market share \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql -Pocatello plant \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Hampered by high energy costs \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Accelerated closure of 3 of 4 furnaces \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Power resale \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql -New PPA plant \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Low-cost North American plant replaces higher-cost thermal \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql phosphorous \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Equivalent of approximately 1/3 of Pocatello output \par\pard\plain\fs16 \page \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Actively pursuing low-cost alternatives to mitigate ongoing consent decree \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql spending \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql -------------------------------------------------------------------------------- \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Slide 27 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Industrial Chemicals Group \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql -------------------------- \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql **2000 Results/ 2001 Forecast: Sales & profits adversely impacted by lower euro \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql & increased energy costs. 2000 sales also appeared lower as Astaris JV began in \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql 2Q 2000. 2001 profits expected to be down slightly \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql **Soda Ash: 2001 volumes flat as strengthening exports offset impact of new \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql entrant; Energy surcharge results still uncertain \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql **Hydrogen Peroxide: Higher prices & volumes in 2000 and 2001, plus reduction in \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql cost base \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql **Phosphorus: Significant power cost impact in `01 & `02, partially offset by \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql resale of power beginning in 2Q 2001. New low cost PPA plant start-up 2Q '01 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql **Foret: Modest improvement expected from low 2000 \par\pard\plain\fs16 \par\pard\plain\fs16 \par\pard\plain\fs16 \par\pard\plain\fs16 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs18\ql [Bar Graph] 1994 1995 1996 1997 1998 1999 2000 \par\pard\plain\fs16\pard\plain\cf1\f50\fs18\ql ------ ------ ------ ------ ------ ------ ------ \par\pard\plain\fs16\pard\plain\cf1\f50\fs18\ql Sales ($ Millions)* $1,027 $1,137 $1,201 $1,173 $1,138 $1,141 $1,106 \par\pard\plain\fs16\pard\plain\cf1\f50\fs18\ql [Overlapping Line Graph] \par\pard\plain\fs16\pard\plain\cf1\f50\fs18\ql % EBITDA Margins 18.3% 20.1% 22.8% 19.5% 17.1% 18.2% 16.0% \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql *Sales include 1/2 of Astaris sales and required shipping costs. \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql [Customer logos: The Gillette Company, Dow, Procter & Gamble, Colgate-Palmolive \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Company, Rohm Haas] \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql -------------------------------------------------------------------------------- \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Slide 28 \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql FMC Corporation Direction \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql ------------------------- \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql FMC Corporation to focus on: \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Growing our position in BioPolymers, and continuing to improve Lithium's \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql profitability \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Improving our cost structure in industrial chemicals \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Expanding herbicide sales in agricultural products and continuing to \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql search for new pesticides through the use of biotechnology \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Managing businesses to grow long-term profitability \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql -------------------------------------------------------------------------------- \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Slide 29 \par\pard\plain\fs16 \par\pard\plain\fs16 \page \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql Summary \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql ------- \par\pard\plain\fs16 \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .IPO of FMC Technologies today \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .Spin-off of FMC Technologies before end of year \par\pard\plain\fs16\pard\plain\cf1\f50\fs16\ql .FMC (Chemicals) company to focus on long-term profitable growth \par\pard\plain\fs16 \par\pard\plain\fs16}